The global fertility services market exhibited strong growth during 2015-2020.
Fertility services refer to the procedures provided as a treatment for infertility. Infertility is defined as the inability to conceive or carry a full-term pregnancy. Among males, it is identified by a low sperm count or is a result of hormonal imbalance in men. For females, infertility refers to the lack of proper functioning of glands such as hypothalamus and pituitary gland that stimulate hormones in the brain to trigger the ovaries to release an egg. Fertility treatments include medications and procedures that increase the chances of pregnancy. They involve fertility drugs, artificial insemination, In Vitro Fertilization (IVF), egg-freezing or oocyte cryopreservation, surrogacy, Assisted Reproductive Technology (ART) procedures, etc. They assist infertile couples, single parents and members of the LGBT community to plan a family.
The expanding career-oriented population base has led to the increasing prevalence of delayed pregnancies, which is contributing significantly to the market growth. Owing to concerns such as expensive childcare services, academic or career ambitions, and a lack of financial stability, people often opt to have children late in life when they are more mature and financially established. However, excessive workload and the accompanying stress along with sedentary lifestyle habits including smoking and consumption of drugs lead to infertility issues among many of them. Moreover, the rising prevalence of various medical ailments such as endometrial tuberculosis, polycystic ovarian syndrome (PCOS) and sexually transmitted diseases (STDs) that can cause infertility, is also projected to catalyze the growth of the market. Additionally, growing awareness among individuals and increasing accessibility to improved healthcare facilities have further increased the adoption of these services in both developed and emerging economies. Other factors such as increasing advertising and promotion of fertility services on televisions and online portals along with the rising disposable incomes and flexible coverage offered by health insurance companies are also augmenting the market growth. Looking forward, the analyst expects the global fertility services market to grow at a CAGR of around 8% during the forecast period (2021-2026).
This latest report provides a deep insight into the global fertility services market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the fertility services market in any manner.
Report Covearge: Historical, Current and Future Market Trends
Market Breakup by Cause of Infertility: Male Infertility Female Infertility
Market Breakup by Procedure: In Vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI) Surrogacy In Vitro Fertilization Without Intracytoplasmic Sperm Injection (IVF without ICSI) Intrauterine Insemination (IUI) Others
Market Breakup by Service: Fresh Non-Donor Frozen Non-Donor Egg and Embryo Banking Fresh Donor Frozen Donor
Market Breakup by End-User: Fertility Clinics Hospitals Surgical Centres Clinical Research Institutes Cryobanks
Market Breakup by Region: Europe North America Asia Pacific Middle East and Africa Latin America
Competitive Landscape: The report has also analysed the competitive landscape of the market with some of the key players being Instituto Bernabe, INVO Bioscience, Monash IVF Group, Apollo Hospitals Enterprise, Care Fertility Group, Carolinas Fertility Institute, Genea Limited, The Cooper Companies, Virtus Health, Vitrolife, The Johns Hopkins Helath System, Medicover Group, Ovascience, Progyny, Xytex Cryo International, etc
Key Questions Answered in This Report: How has the global fertility services market performed so far and how will it perform in the coming years? What are the key regional markets in the global fertility services industry? What has been the impact of COVID-19 on the global fertility services market? What is the breakup of the market based on the cause of infertility? What is the breakup of the market based on the procedure? What is the breakup of the market based on the service? What is the breakup of the market based on the end-user? What are the various stages in the value chain of the global fertility services industry? What are the key driving factors and challenges in the global fertility services industry? What is the structure of the global fertility services industry and who are the key players? What is the degree of competition in the global fertility services industry?
Our reports have been used by over 10K customers, including:
The cardiac rehabilitation market is expected to reach US$ 2,865.42 million by 2028 from US$ 1,780.98 million in 2020; it is estimated to grow at a CAGR of 6.12% during 2020-2028. The growth of the market is mainly attributed to the key driving factors such as the rising incidences of cardiovascular diseases and growing adoption of tele-cardiac...
The medical second opinion market was valued at US$ 3,204.57 million in 2019 and is projected to reach US$ 10,739.48 million by 2027; it is expected to grow at a CAGR of 16.32% during 2020-2028. The growth of the medical second opinion market is mainly attributed to the increasing prevalence of chronic diseases, growing emphasis on superior...
The health and medical insurance market is expected to register a healthy CAGR of 5.05%, during the forecast period (2021-2026). Market for private healthcare services projected to reach USD 13.8 Bn by 2025 due to rise in NHS waiting times and referrals to the private sector. Health cover has become the highest public priority. Healthcare...
175 pages •
By The Business Research Company
• Jul 2021
Major players in the hospital daily cash benefit insurance market are Cigna Corporation, AIA Insurance Group, UnitedHealth Group Inc., Allianz SE, Zurich Insurance Group Ltd., Express Scripts Holding Company, AXA, Aviva plc, Aetna Inc., and Apollo Munich Health Insurance. The global hospital daily cash benefit insurance market is expected...
This IDC study discusses how healthcare organizations are on a mission to digitally transform to create a value-based healthcare system, even though they may not use the term digital transformation as extensively as other industries such as retail or financial services do. While the pandemic drove unprecedented adoption of virtual visits and...
The global lung marker market is expected to exhibit strong growth during 2021-2026. Generally, four major types of lung markers, including EGFR, EML4-ALK, KRAS, and BRAF, are used during lung intervention procedures or lung surgeries and diagnosis. Furthermore, the markers are used to detect, diagnose, predict, and...
The global medical tourism market is expected to exhibit strong growth during 2021-2026. Medical tourism refers to organized travel across countries to receive medical treatment. It usually involves traveling abroad for maintenance, enhancement or restoration of health through advanced healthcare facilities and treatment...
The Asia Pacific cardiac rehabilitation market is expected to reach US$ 566.21 million by 2028 from US$ 357.64 million in 2021; it is estimated to grow at a CAGR of 6.8% from 2021 to 2028. The growth of the market is attributed to some key driving factors such as rise in technologically advanced cardiac rehabilitation products and supportive...
The Middle East and Africa cardiac rehabilitation market is expected to reach US$ 90.26 million by 2028 from US$ 59.97 million in 2020; it is estimated to grow at a CAGR of 5.3% from 2021 to 2028. The growth of the market is attributed to key driving factors such as growing adoption of tele-cardiac rehabilitation and supportive government...
The North America cardiac rehabilitation market is expected to reach US$ 1,258.21 million by 2028 from US$ 809.40 million in 2021; it is estimated to grow at a CAGR of 6.5% from 2021 to 2028. The growth of the market is attributed to key driving factors such as rising incidences of cardiovascular diseases, and growing adoption of tele-cardiac...
Cause-Specific Mortality Rate
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.